U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C5H3ClN4
Molecular Weight 154.557
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of 6-CHLOROPURINE

SMILES

ClC1=NC=NC2=C1N=CN2

InChI

InChIKey=ZKBQDFAWXLTYKS-UHFFFAOYSA-N
InChI=1S/C5H3ClN4/c6-4-3-5(9-1-7-3)10-2-8-4/h1-2H,(H,7,8,9,10)

HIDE SMILES / InChI

Molecular Formula C5H3ClN4
Molecular Weight 154.557
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Approval Year

PubMed

PubMed

TitleDatePubMed
Semisynthesis of 6-chloropurine-2'-deoxyriboside 5'-dimethoxytrityl 3'-(2-cyanoethyl-N,N-diisopropylamino)phosphoramidite and its use in the synthesis of fluorescently labeled oligonucleotides.
2010-11
DNA oligomers containing site-specific and stereospecific exocyclic deoxyadenosine adducts of 1,2,3,4-diepoxybutane: synthesis, characterization, and effects on DNA structure.
2010-10-18
Direct synthesis of 6-arylpurines by reaction of 6-chloropurines with activated aromatics.
2010-09-03
Photochemical synthesis of nucleoside analogues from cyclobutanones: bicyclic and isonucleosides.
2010-05-26
Symmetrical and unsymmetrical alpha,omega-nucleobase amide-conjugated systems.
2010-04-12
Microwave-assisted syntheses of nucleosides and their precursors.
2010-02
15N and 13C NMR chemical shifts of 6-(fluoro, chloro, bromo, and iodo)purine 2'-deoxynucleosides: measurements and calculations.
2010-01
Synthesis of modified homo-N-nucleosides from the reactions of mesityl nitrile oxide with 9-allylpurines and their influence on lipid peroxidation and thrombin inhibition.
2009-11-15
Kinetic analysis of base-pairing preference for nucleotide incorporation opposite template pyrimidines by human DNA polymerase iota.
2009-06-05
Identifying the features of purine dNTPs that allow accurate and efficient DNA replication by herpes simplex virus I DNA polymerase.
2009-04-21
Additive Pummerer reaction of 3,5-O-(di-tert-butyl)silylene-4-thiofuranoid glycal: a high-yield and beta-selective entry to 4'-thioribonucleosides.
2009-03-20
Activation of IP(3) receptors by synthetic bisphosphate ligands.
2009-03-14
Synthesis, characterization and biological activity of ring-substituted 6-benzylamino-9-tetrahydropyran-2-yl and 9-tetrahydrofuran-2-ylpurine derivatives.
2009-03-01
Synthesis of 6,8,9-tri- and 2,6,8,9-tetrasubstituted purines by a combination of the Suzuki cross-coupling, N-arylation, and direct C-H arylation reactions.
2008-11-21
Neo-clinicians, clinical trials, and the reorganization of medical research in Paris hospitals after the Second World War: the trajectory of Jean Bernard.
2008-10
Bicyclic nucleoside synthesis: a photochemical approach.
2008-05
Facile synthesis of 1',2'-cis-beta-pyranosyladenine nucleosides.
2007-12-10
A novel noninvasive method for assessing glutathione-conjugate efflux systems in the brain.
2007-05-01
Synthesis and biological evaluation of nucleoside analogues having 6-chloropurine as anti-SARS-CoV agents.
2007-05-01
Palladium-catalyzed cross-coupling reactions in c6 modifications of purine nucleosides.
2007-03
Synthesis and anti-HCV activity Of 2''-beta-hydroxymethylated nucleosides.
2007
Suppression of subgenomic hepatitis C virus replication by 5'-O-masked analogues of 6-chloropurine-2'-deoxyriboside.
2007
A synthetic route to 9-(polyhydroxyalkyl)purines.
2006-09-25
Synthesis of fluorinated nucleosides.
2006-07
Preparation and biological activity of 6-benzylaminopurine derivatives in plants and human cancer cells.
2006-02-01
De novo asymmetric synthesis of homoadenosine via a palladium-catalyzed N-glycosylation.
2006-01-19
Synthesis of novel 4'-carbon-substituted BCA derivatives based on radical cyclization.
2006
Anti-SARS-CoV activity of nucleoside analogs having 6-chloropurine as a nucleobase.
2006
Traceless solid-phase synthesis of N1,N7-disubstituted purines.
2005-09-13
Cytostatic 6-arylpurine nucleosides. 6. SAR in anti-HCV and cytostatic activity of extended series of 6-hetarylpurine ribonucleosides.
2005-09-08
Preparation of a fully substituted purine library.
2005-05-10
The mechanism of selective purine C-nitration revealed: NMR studies demonstrate formation and radical rearrangement of an N7-nitramine intermediate.
2005-04-27
Evidence for Watson-Crick and not Hoogsteen or wobble base pairing in the selection of nucleotides for insertion opposite pyrimidines and a thymine dimer by yeast DNA pol eta.
2005-03-29
Microwave-assisted amination of a chloropurine derivative in the synthesis of acyclic nucleoside analogues.
2005-02-28
The novel pyrimidine and purine derivatives of l-ascorbic acid: synthesis, one- and two-dimensional 1H and 13C NMR study, cytostatic and antiviral evaluation.
2005-01-03
Transition-metal-mediated synthesis of novel carbocyclic nucleoside analogues with antitumoral activity.
2004-10-11
Conformationally constrained purine mimics. Incorporation of adenine and guanine into spirocyclic nucleosides.
2004-08-20
SNAr iodination of 6-chloropurine nucleosides: aromatic Finkelstein reactions at temperatures below -40 degrees C.
2004-08-19
Asymmetric synthesis of novel thioiso dideoxynucleosides with exocyclic methylene as potential antiviral agents.
2004-04-30
A novel synthesis of malondialdehyde adducts of deoxyguanosine, deoxyadenosine, and deoxycytidine.
2004-02
Synthesis and biological evaluation of disubstituted N6-cyclopentyladenine analogues: the search for a neutral antagonist with high affinity for the adenosine A1 receptor.
2004-01-02
Molecular design of novel spin-labeled nucleosides directly attached base moiety.
2004
Synthesis of base substituted 2-hydroxy-3-(purin-9-yl)-propanoic acids and 4-(purin-9-yl)-3-butenoic acids.
2003-12
Synthesis and Ca2+-mobilizing activity of purine-modified mimics of adenophostin A: a model for the adenophostin-Ins(1,4,5)P3 receptor interaction.
2003-11-06
Introduction of a benzyl group onto the 2'-OH of 6-chloropurine 3'-O-benzoylriboside.
2003-10-21
[Synthesis and biological activity of pseudonucleotides based on the evolution hypothesis of the glycocomponent of nucleic acid].
2003-09-01
The yeast ISN1 (YOR155c) gene encodes a new type of IMP-specific 5'-nucleotidase.
2003-05-07
A new method for the synthesis of 2'-O-benzyladenosine using Mitsunobu reaction.
2003-02
Structure-activity relationships for the binding of ligands to xanthine or guanine phosphoribosyl-transferase from Toxoplasma gondii.
1995-11-09
Purine analogs as potential anticytomegalovirus agents.
1969-09
Patents
Substance Class Chemical
Created
by admin
on Mon Mar 31 17:45:11 GMT 2025
Edited
by admin
on Mon Mar 31 17:45:11 GMT 2025
Record UNII
OH8700156W
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
6-CHLOROPURINE
MI  
Systematic Name English
NSC-744
Preferred Name English
6-CHLOROPURINE [MI]
Common Name English
6-CHLORO-9H-PURINE
Systematic Name English
Code System Code Type Description
CAS
87-42-3
Created by admin on Mon Mar 31 17:45:12 GMT 2025 , Edited by admin on Mon Mar 31 17:45:12 GMT 2025
PRIMARY
NSC
744
Created by admin on Mon Mar 31 17:45:12 GMT 2025 , Edited by admin on Mon Mar 31 17:45:12 GMT 2025
PRIMARY
PUBCHEM
5359277
Created by admin on Mon Mar 31 17:45:12 GMT 2025 , Edited by admin on Mon Mar 31 17:45:12 GMT 2025
PRIMARY
SMS_ID
300000000020
Created by admin on Mon Mar 31 17:45:12 GMT 2025 , Edited by admin on Mon Mar 31 17:45:12 GMT 2025
PRIMARY
ECHA (EC/EINECS)
201-745-6
Created by admin on Mon Mar 31 17:45:12 GMT 2025 , Edited by admin on Mon Mar 31 17:45:12 GMT 2025
PRIMARY
MERCK INDEX
m3433
Created by admin on Mon Mar 31 17:45:12 GMT 2025 , Edited by admin on Mon Mar 31 17:45:12 GMT 2025
PRIMARY Merck Index
EPA CompTox
DTXSID00861673
Created by admin on Mon Mar 31 17:45:12 GMT 2025 , Edited by admin on Mon Mar 31 17:45:12 GMT 2025
PRIMARY
FDA UNII
OH8700156W
Created by admin on Mon Mar 31 17:45:12 GMT 2025 , Edited by admin on Mon Mar 31 17:45:12 GMT 2025
PRIMARY